Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
3-1 Month Momentum % is the total return of the stock from 3-month ago to 1-month ago. As of today (2026-07-29), Clover Health Investments's 3-1 Month Momentum % is 104.92%.
The industry rank for Clover Health Investments's 3-1 Month Momentum % or its related term are showing as below:
CLOV's 3-1 Month Momentum % is ranked better than 94.44% of 18
companies
in the Healthcare Plans industry
Industry Median: 7.415
vs CLOV: 104.92
Clover Health Investments (NAS:CLOV) 3-1 Month Momentum % Explanation
Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 3-1 Month Momentum % measures the total return to a stock over the past three months, but ignores the previous month.
The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.
Clover Health Investments 3-1 Month Momentum % Related Terms
CLOV vs PGNY, ALHC, PFHO: 3-1 Month Momentum % Comparison
For the Healthcare Plans subindustry, Clover Health Investments's 3-1 Month Momentum %, along with its competitors' market caps and 3-1 Month Momentum % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Clover Health Investments 3-1 Month Momentum % vs Healthcare Plans Industry
For the Healthcare Plans industry and Healthcare sector, Clover Health Investments's 3-1 Month Momentum % distribution charts can be found below:
* The bar in red indicates where Clover Health Investments's 3-1 Month Momentum % falls into.
Clover Health Investments (NAS:CLOV) 3-1 Month Momentum % Calculation
3-1 Month Momentum % is calculated as following:
3-1 Month Momentum %
=
( Price 1-month ago
/
Price 3-month ago
- 1 )
*
100 %
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Clover Health Investments (CLOV) has a 3-1 Month Momentum % of 104.92% as of Jul. 29, 2026. 3-1 Month Momentum measures the total return of the stock from 3-month ago to 1-month ago. View historical data on Clover Health Investments and its competitors. According to the industry distribution chart, Clover Health Investments ranks #1 out of 18 companies in the Healthcare Plans industry, placing it in the top 5.6%.
Is Clover Health Investments' 3-1 Month Momentum % too high?
Clover Health Investments' current 3-1 Month Momentum % is 104.92%. The Healthcare Plans industry median 3-1 Month Momentum % is 7.42. Clover Health Investments' value of 104.92% is 1315% above this industry median. Based on the distribution chart, Clover Health Investments ranks #1 out of 18 companies in the Healthcare Plans industry, which is in the top quartile — a strong position relative to peers. Overall, Clover Health Investments has a GF Score™ of 83/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Clover Health Investments' 3-1 Month Momentum % compare to PGNY and ALHC?
According to the Healthcare Plans industry distribution chart, Clover Health Investments ranks #1 out of 18 companies for 3-1 Month Momentum %. This places Clover Health Investments in the top 6% of its industry — outperforming the majority of peers. The industry median 3-1 Month Momentum % is 7.42. Clover Health Investments' value of 104.92% is 1315% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-1 Month Momentum % for a Healthcare Plans company?
The median 3-1 Month Momentum % among Healthcare Plans companies is 7.42, based on 18 companies in the industry. Companies in the top quartile (top 25%) have a 3-1 Month Momentum % significantly above this median, while those in the bottom quartile fall well below. However, 3-1 Month Momentum % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Clover Health Investments's current 3-1 Month Momentum % of 104.92% is 1315% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-1 Month Momentum % mean?
A high 3-1 Month Momentum % can signal that a stock is expensive relative to its fundamentals. 3-1 Month Momentum measures the total return of the stock from 3-month ago to 1-month ago. View historical data on Clover Health Investments and its competitors. For the Healthcare Plans industry, the median 3-1 Month Momentum % is 7.42 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Clover Health Investments's current 3-1 Month Momentum % is 104.92%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Clover Health Investments stock overvalued right now?
Based on GuruFocus' analysis, Clover Health Investments (CLOV) is currently considered Fairly Valued. The stock's GF Value™ is $4.08, compared to a current price of $4.34 — trading 6.3% above its estimated fair value. The current 3-1 Month Momentum % is 104.92% and 1315% above the Healthcare Plans industry median of 7.42. Clover Health Investments' overall GF Score™ is 83/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-1 Month Momentum % calculated?
3-1 Month Momentum % is calculated from a company's financial statements. For Clover Health Investments (CLOV), the current 3-1 Month Momentum % is 104.92% as of Jul. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Clover Health Investments (CLOV) Overvalued in 2026?
Based on GuruFocus' analysis, Clover Health Investments stock appears to be overvalued.
The current stock price of $4.34 is trading 6.3% above its estimated GF Value™ of $4.08.
GuruFocus considers Clover Health Investments to be Fairly Valued.
Key valuation signals for CLOV:
3-1 Month Momentum %: 104.92%
GF Value™: $4.08 vs. price of $4.34 (6.3% above fair value)
Industry Position: 1315% above the Healthcare Plans median (#1 of 18)
No single metric tells the full story. See the CLOV stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Clover Health Investments Corp is a healthcare technology company. It focuses on empowering Medicare physicians to proactively manage chronic diseases through its proprietary software platform, Clover Assistant. This cloud-based solution provides personalized insights to physicians, enabling early detection and management of chronic conditions. It operates in one segment: Insurance, through which it offers PPO and HMO plans to Medicare Advantage members in several states.
83GF Score
Get the complete analysis for CLOV
3-1 Month Momentum % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CLOV has been successfully added to your 
